arrow
V

Vilija Jokubaitis

monash university
H指数:37
被引数:5,232

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How patients with neuromyelitis optica spectrum disease accumulate disability

视神经脊髓炎谱系疾病患者如何累积残疾

2026-10-080
PRE
Lymphocyte count polygenicity underlies dimethyl fumarate–associated lymphopenia in multiple sclerosis

多基因性是导致多发性硬化症患者二甲基佛波酯相关淋巴细胞减少的淋巴ocyte count polygenicity underlies dimethyl fumarate–associated lymphopenia in multiple sclerosis

2026-08-170
PRE
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study

在记录有化疗暴露的人群中,癌症诊断后的多发性硬化结局:一项真实世界MSBase研究

2026-08-020
PRE
Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotype

神经疾病基因中的罕见变异及其在多发性硬化症模拟和表型中的作用

2025-12-100
OAAI
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial

多中心、随机、双盲、安慰剂对照、多臂、多阶段临床试验研究方案:评估螺内酯(SpironolacTone)和泛昔洛韦(famciclOovir)治疗进展性多发性硬化以预防残疾进展:STOP-MS试验

2025-12-010
OA
Disease course after pregnancy in women with progressive multiple sclerosis symptoms

妊娠后进展性多发性硬化症状女性的疾病病程

2025-09-200
OA
Persistent progression independent of relapse activity in multiple sclerosis

多发性硬化中与复发活动无关的持续性进展

2025-08-210
OAAI
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

四年之后:MSBase妊娠、新生儿结局及女性健康登记册(2020–2024)中报告的妊娠与分娩结局

2025-07-070
PRE
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies
2024-11-012
OAAI
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
2024-09-040
PRE
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
2024-03-074
PRE